DAVID MOLTHROP, M.D.
Medical Oncology Physician · WINTER PARK, FL
Individual Active NPI 1194783027
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,032 | 213,234 | $14,309,790 | $5,090,154 | $4,050,300 |
| 2023 | 987 | 210,720 | $11,774,453 | $4,081,004 | $3,246,686 |
| 2022 | 947 | 162,075 | $9,562,768 | $3,410,314 | $2,734,250 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 19,400 | $56 | $45 |
| J0185 | Injection, aprepitant, 1 mg | 15,080 | $2 | $1 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 4,980 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,230 | $0 | $0 |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 2,804 | $8 | $8 |
| 36415 | Insertion of needle into vein for collection of blood sample | 2,670 | $9 | $9 |
| J9395 | Injection, fulvestrant, 25 mg | 2,460 | $8 | $6 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,260 | $8 | $6 |
| Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | 2,150 | $40 | $32 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2,130 | $1 | $1 |
| J0897 | Injection, denosumab, 1 mg | 1,860 | $25 | $20 |
| 96375 | Injection of additional new drug or substance into vein | 1,187 | $14 | $11 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | ME65259 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Florida
- NPI 1083146005
- NPI 1942838032
- NPI 1821309410
- NPI 1407055973
- NPI 1336466622
- NPI 1073571964
- NPI 1891753729
- NPI 1407804578
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.